Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel for No-Reflow in STEMI
NCT02798874Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ticagrelor in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Prevalence of no-reflow. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02798874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798874.